Back

Natriuretic Peptide Metabolisation is Associated with Clinical Outcome in Chronic Heart Failure: a Step Towards Personalized Heart Failure Guidance

3 September 2019 (15:06 - 15:24)
Organised by:
Congress Presentation Part of: Late Breaking Science in Heart Failure 2 Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Roland van Kimmenade

Zuyderland Medical Centre, Heerlen (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Dynamic changes in cardiac structures: novel aspects of the pathophysiology of heart failure with preserved left ventricular ejection fraction -a report from the CHART-2 Study-
Professor H. Shimokawa (Sendai, JP)
Slides Video
Presentation thumbnail
Diabetes and heart failure after acute myocardial infarction. The FAST-MI programme
Professor N. Danchin (Paris, FR)
Slides Video
Presentation thumbnail
Current characteristics and treatment of patients with heart failure with reduced ejection fraction in outpatients in Europe.Baseline results of ARIADNE
Doctor A. Maggioni (Florence, IT)
Slides Video
Presentation thumbnail
Association between beta-blocker use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study
Professor G. Savarese (Stockholm, SE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Heart Failure 2

The Event

Event poster

ESC Congress 2019

3 September 2019 15:06 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources